Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model

Cancer Immunology Immunotherapy

Volumn 48, Issue 4, 1999, Pages 165-171

  Yamamoto, Takafumi ^a   Arakawa, Fumiko ^a   Nakamura, Ken ^a   Senba, Tarumi ^a   Tomita, Yoshihiro ^a   Ikeda, Seiyo ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

ADCC; Apoptosis; Immunotherapy; MK 1 antigen Chimeric antibody

Indexed keywords

ANTIGEN; CHIMERIC ANTIBODY; GLYCOPROTEIN; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, NEOPLASM; APOPTOSIS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032818043     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050561     Document Type: Article

References (36)

1. 1. Arakawa F, Haruno M, Kuroki M, Kanda H, Watanabe T, Misumi Y, Matsuoka Y (1993) Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Hybridoma 12:365
2. 2. Berke G (1991) Debate: the mechanism of lymphocyte-mediated killing. Lymphocyte-triggered internal target disintegration. Immunol Today 12:396
3. 3. Curnow SJ, Glennie MJ, Stevenson GT (1993) The role of apoptosis in antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother 36:149
4. 4. Duke RC, Cohen JJ, Chervenak R (1986) Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. J Immunol 137:1442
5. 5. Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PJ (1996) Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 156:2693
6. 6. Gill I, Agah R, Hu E, Mazumder A (1989) Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo. Cancer Res 49:5377
7. 7. Hayashi H, Tatebe S, Osaki M, Goto A, Suzuki Y, Ito H (1997) Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jpn J Cancer Res 88:49
8. 8. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1979) Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76:1438
9. 9. Herlyn D, Herlyn M, Ross AH, Ernst C, Atkinson B, Koprowski H (1984) Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 73:157
10. 10. Herlyn D, Sears HF, Ernst CS, Iliopoulos D, Steplewski Z, Koprowski H (1991) Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma. Am J Clin Oncol 14:371
11. 11. Honsik CJ, Jung G, Reisfeld RA (1986) Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin. Proc Natl Acad Sci USA 83:7893
12. 12. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z (1994) Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15:237
13. 13. Knight CR, Rees RC, Platts A, Johnson T, Griffin M (1993) Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells. Immunology 79:535
14. 14. Kuwahara M, Kuroki M, Haruno M, Murakami M, Arakawa F, Oikawa S, Nakazato H, Matsuoka Y (1994) A rapid colorimetric assay for carcinoembryonic antigen (CEA)-mediated cell adhesion and analysis of CEA domains involved in the adhesion. Immunol Invest 23:367
15. 15. Larson LN, Johansson C, Lindholm L, Holmgren J (1988) Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells. Int J Cancer 42:877
16. 16. Liu Y, Mullbacher A, Waring P (1989) Natural killer cells and cytotoxic T cells induce DNA fragmentation in both human and murine target cells in vitro. Scand J Immunol 30:31
17. 17. LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Ghrayeb J, Sun L, Khazaeli MB (1989) Mouse/ human chimeric monoclonal antibody in man: Kinetics and immune response. Proc Natl Acad Sci USA 86:4220
18. 18. Morrison SL (1985) Transfectomas provide novel chimeric antibodies. Science 229:1202
19. 19. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256
20. 20. Munn DH, Cheung NK (1987) Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer Res 47:6600
21. 21. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M (1996) Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 111:156
22. 22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271
23. 23. Riethmüller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichlmaier H, Kirche H, Pichlmaier R, Buggisch P, Witte J (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Duke's C colorectal carcinoma. Lancet 343:1177
24. 24. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC, Jr (1985) Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45:879
25. 25. Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y (1998) Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Anticancer Res 18:17
26. 26. Shetye J, Frodin JE, Christensson B, Grant C, Jacobsson B, Sundelius S, Sylven M, Biberfeld P, Mellstedt H (1988) Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunol Immunother 27:154
27. 27. Shi L, Kraut RP, Aebersold R, Greenberg AH (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175:553
28. 28. Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P, Koprowski H (1988) Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci USA 85:4852
29. 29. Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H, Linnenbach AJ (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87:3542
30. 30. Telford WG, King LE, Fraker PJ (1994) Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 172:1
31. 31. Trang JM, LoBuglio AF, Wheeler RH, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB (1990) Pharmacokinetics of a mouse/ human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients. Pharm Res 7:587
32. 32. Varki NM, Reisfeld RA, Walker LE (1984) Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res 44:681
33. a) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID mice. Cancer Immunol Immunother 37:245
34. 34. Watanabe R, Johzaki H, Iwasaki H, Kikuchi M, Ikeda S (1993) A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma. Cancer 71:2439
35. 35. Young JD (1989) Killing of target cells by lymphocytes: a mechanistic view. Physiol Rev 69:250
36. 36. Zychlinsky A, Zheng LM, Liu CC, Young JD (1991) Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 146:393